SORAFENIB TABLETS 200MG

Sorafenib Tablets 200mg are prescription oral anticancer medicines classified as multikinase inhibitors. They are highly effective in managing advanced cancers such as hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and differentiated thyroid carcinoma. Prescribed by oncologists, these tablets are a key part of targeted cancer therapy.

Sorafenib Tablets 200 mg work by blocking tumor cell proliferation and inhibiting angiogenesis, which is the formation of new blood vessels that feed cancer growth. By disrupting these critical processes, sorafenib helps slow cancer progression and improve patient outcomes when used under medical supervision.

Taken orally, Sorafenib Tablets 200 mg provide a convenient treatment option for patients with advanced cancers. The dosage and schedule are tailored by healthcare professionals to ensure maximum therapeutic effect while monitoring for potential side effects, making it a trusted choice in oncology care.

Product Features

• Multikinase inhibitor targeted therapy
• Used in liver, kidney, and thyroid cancers
• Inhibits tumor growth and blood vessel formation
• Oral tablet for convenient administration
• Suitable for long-term cancer management
• Prescription-only oncology medication

How It Helps

• Blocks cancer cell growth by inhibiting tumor proliferation
• Prevents the formation of new blood vessels (angiogenesis) that feed tumors
• Effective in treating liver, kidney, and thyroid cancers
• Slows the progression of advanced cancers under medical supervision